January 1, 2015 Commonalities And Challenges In The Development Of Clinical Trial Measures In Neurology
January 12, 2014 Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop
January 7, 2014 Coalition Against Major Diseases/European Medicines Agency Biomarker Qualification Of Hippocampal Volume For Enrichment Of Clinical Trials In Predementia Stages Of Alzheimer’s Disease
January 4, 2014 Operationalizing Hippocampal Volume as an Enrichment Biomarker for Amnestic Mild Cognitive Impairment Trials: Effect of Algorithm, Test-Retest Variability, and Cut Point on Trial Cost, Duration, and Sample Size
January 8, 2013 Understanding Placebo Responses In Alzheimer’s Disease Clinical Trials From The Literature Meta-data And CAMD Database
January 10, 2012 Combining Patient-level And Summary-level Data For Alzheimer’s Disease Modeling And Simulation: A Β Regression Meta-analysis
January 9, 2010 Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success